1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial

Authors:

Abstract
No abstract available
Funding Information
  • Abbott Japan

This publication has 35 references indexed in Scilit: